Skip to main content

FDA meeting to evaluate COVID-19 vaccines for children as young as six months

The Food and Drug Administration is poised to approve the Pfizer and Moderna vaccines for children as young as six months on Wednesday, the final age group to receive approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.